|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2005-7-4
|
|
pubmed:abstractText |
Randomized studies on tamoxifen treatment of hepatocellular carcinoma (HCC) produced conflicting results. The aim of this study was to assess the efficacy of tamoxifen administration in improving overall survival of patients with advanced HCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AbergelArmandA,
pubmed-author:BarbareJean-ClaudeJC,
pubmed-author:BedenneLaurentL,
pubmed-author:BlanchiAlainA,
pubmed-author:BoigeValérieV,
pubmed-author:BonnetainFranckF,
pubmed-author:BouchéOlivierO,
pubmed-author:DenisBernardB,
pubmed-author:MilanChantalC,
pubmed-author:ParienteAlexandreA,
pubmed-author:RaoulJean-LucJL,
pubmed-author:RougierPhilippeP
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4338-46
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15994145-Aged,
pubmed-meshheading:15994145-Antineoplastic Agents, Hormonal,
pubmed-meshheading:15994145-Carcinoma, Hepatocellular,
pubmed-meshheading:15994145-Female,
pubmed-meshheading:15994145-Humans,
pubmed-meshheading:15994145-Liver Neoplasms,
pubmed-meshheading:15994145-Male,
pubmed-meshheading:15994145-Middle Aged,
pubmed-meshheading:15994145-Quality of Life,
pubmed-meshheading:15994145-Survival Rate,
pubmed-meshheading:15994145-Tamoxifen
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
|
|
pubmed:affiliation |
Service d'Hépato-Gastroentérologie, Centre Hospitalier, 8 avenue Henri Adnot, 60321 Compiègne, France. jcbarbare001@ch-compiegne.rss.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
